Global Medtech Mergers and Acquisitions (M&As) Growth Opportunities
Competitive Intensity and Innovative Business Models are Driving a Large Number of Acquisitions in the Medtech Industry
16-Nov-2021
Global
Market Research
MG5B-01-00-00-00
HC03468-GL-MT_25952
The healthcare industry has been adapting to changes induced by the COVID-19 pandemic. Medtech, for its part, has been pursuing mergers and acquisitions (M&As) to implement reforms and help the industry recover. Companies in the traditional clinical segments in medtech, such as orthopedics, cardiology, ear, nose, and throat (ENT), wound care, urology, and respiratory care, registered several notable acquisitions and signed a number of deals with companies in emerging segments like women’s health, connectivity solutions, home-based care, infection prevention, patient monitoring, and integrated operating room (OR).
Acquisitions have become the preferred way for companies to include new technologies, capabilities, or solutions to their existing product portfolios. Some companies made acquisitions to expand their presence in different regions or segments. The impact of the COVID-19 pandemic led some companies that were struggling to reduce debt or recover losses to make certain divestitures. Several companies also made divestitures to focus on the company’s organic growth or invest in robotic surgery, a key disruptive technology. This study examines the different mergers and acquisitions in the medtech industry, analyses the trends driving them, and identifies the growth opportunities for the next few years.
Author: Suchismita Das
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Medtech Mergers and Acquisitions (M&As)
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Global M&As Segmentation
Important Definitions
Growth Drivers for Medtech M&As
Growth Restraints for Medtech M&As
How is the Medtech Industry Evolving with M&As?
Global Medtech M&As Scenario Analysis
Tidal Wave of Merger Filings—Overwhelmed FTC Announces That it May Challenge Some Mergers Later
Number of Acquisitions and Deal Sizes Between January 2019 and August 2021
Acquisitions by Medtech Segments
Deals Investment Amount from Medtech Acquisitions
Reasons for Medtech Acquisitions
Reasons for Medtech Acquisitions (continued)
Medtech Acquisitions Deal Analysis
Medtech Acquisitions Deal Analysis (continued)
Medtech Acquisitions Deal Analysis (continued)
Top 5 Trends in Medtech Investments—Acquisitions
Impact of Acquisitions on the Ecosystem
Impact of Acquisitions on the Ecosystem (continued)
Number of Divestitures and Deal Sizes
Divestitures Number by Segments
Divestitures by Deal Size and Segments
Reasons for Medtech Divestitures
Medtech Divestitures Deal Analysis
Top 5 Trends in Medtech Investments—Divestitures
Baxter Acquires Hill-Rom to Integrate Connected Care with its Existing Portfolio of Dialysis Technology and Infusion Pumps
STERIS Acquires Cantel to Enhance its Infection Prevention Portfolio, and J&J Divests its ASP to Fortive Corporation to Focus on its Organic Growth
3M Acquires Acelity to Strengthen its Advanced Wound Care Position, and Siemens Healthineers Acquires Varian Medical to Provide All-comprehensive Cancer Care
Growth Opportunity 1: Robotic Surgical Innovations Witness a Huge Surge, 2020
Growth Opportunity 1: Robotic Surgical Innovations Witness a Huge Surge, 2020 (continued)
Growth Opportunity 2: Increased Acquisitions to Enhance Connected Care Capabilities, 2020
Growth Opportunity 2: Increased Acquisitions to Enhance Connected Care Capabilities, 2020 (continued)
Growth Opportunity 3: Pandemic-induced Transformation in the Medtech Industry Accelerates the Innovation and Adoption of Digital Solutions, 2020
Growth Opportunity 3: Pandemic-induced Transformation in the Medtech Industry Accelerates the Innovation and Adoption of Digital Solutions, 2020 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
Appendix—List of Acquisitions and Divestitures: 2019–2021 (continued)
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
19 Nov 2026 | Global | Technology Research
Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms
Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.